Addressing Dementia Via Agitation-Centered Evaluation

Clinical trial NCT03226522 · COMPLETED

Trial details

NCT number: NCT03226522
Sponsor: Axsome Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Agitation in Patients With Dementia of the Alzheimer's Type Alzheimer Disease Agitation,Psychomotor

Start date: 2017-07-13
Primary completion: 2020-04-17
Enrollment: 366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.